Risdiplam: Therapeutic Effects and Tolerability in a Small Cohort of 6 Adult Type 2 and Type 3 SMA Patients (P11-11.018)
To describe the effect of Risdiplam on a cohort of 6 adult SMA patients using Motor Function Measure (MFM32) score as standardized scale to quantify motor improvements induced by therapy.
Authors
- Edoardo Malfatti (ORCID: https://orcid.org/0000-0001-7871-8600)
- Gianmarco Severa
- Christophe Alimi-Ichola
Institutions
- Paris-Est Sup (FR)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211899
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00